Efficacy of mometasone nasal spray in the treatment of otitis media with effusion in the pediatric age group

A preliminary study

Shalini Menon, Abdul Rahman, Ramaswamy Balakrishnan, Dipak Nayak, Kailesh Pujary

Research output: Contribution to journalArticle

Abstract

Aims: To study the efficacy of mometasone furoate monohydrate topical nasal spray in the treatment of otitis media with effusion (OME) in children aged between 4 and 15 years. Thus, by comparative analysis of results, at 0 and 6 weeks of using mometasone nasal spray, its efficacy in improving the clinical and audiological status of children with OME is assessed. Materials and Methods: A prospective, clinical study carried out on 22 children aged between 4 and 15 years who had attended our Department of Otolaryngology in a tertiary care hospital from January 2008 to May 2009. Results: The efficacy of mometasone furoate monohydrate topical nasal spray in the resolution of middle ear fluid in children aged between 4 and 15 years with OME in this study group was observed to be significant (52.7%). A significant improvement in the overall symptoms was seen in the treatment group. There was good improvement in the audiological status also. Conclusion: Topical steroids can be an alternative to surgery in controlling OME. However, these results are only short-term; a long-term follow-up is necessary. Topical intranasal mometasone furoate therapy can be considered a good therapeutic option to OME. Nasal administration of this steroid is safe, reproducible, easily performed, and well tolerated by pediatric patients.

Original languageEnglish
Pages (from-to)114-117
Number of pages4
JournalIndian Journal of Otology
Volume19
Issue number3
DOIs
Publication statusPublished - 01-07-2013

Fingerprint

Mometasone Furoate
Nasal Sprays
Otitis Media with Effusion
Age Groups
Pediatrics
Steroids
Therapeutics
Intranasal Administration
Otolaryngology
Middle Ear
Tertiary Healthcare
Tertiary Care Centers
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

@article{404b67db9b50496d9a5603f7527a4ed0,
title = "Efficacy of mometasone nasal spray in the treatment of otitis media with effusion in the pediatric age group: A preliminary study",
abstract = "Aims: To study the efficacy of mometasone furoate monohydrate topical nasal spray in the treatment of otitis media with effusion (OME) in children aged between 4 and 15 years. Thus, by comparative analysis of results, at 0 and 6 weeks of using mometasone nasal spray, its efficacy in improving the clinical and audiological status of children with OME is assessed. Materials and Methods: A prospective, clinical study carried out on 22 children aged between 4 and 15 years who had attended our Department of Otolaryngology in a tertiary care hospital from January 2008 to May 2009. Results: The efficacy of mometasone furoate monohydrate topical nasal spray in the resolution of middle ear fluid in children aged between 4 and 15 years with OME in this study group was observed to be significant (52.7{\%}). A significant improvement in the overall symptoms was seen in the treatment group. There was good improvement in the audiological status also. Conclusion: Topical steroids can be an alternative to surgery in controlling OME. However, these results are only short-term; a long-term follow-up is necessary. Topical intranasal mometasone furoate therapy can be considered a good therapeutic option to OME. Nasal administration of this steroid is safe, reproducible, easily performed, and well tolerated by pediatric patients.",
author = "Shalini Menon and Abdul Rahman and Ramaswamy Balakrishnan and Dipak Nayak and Kailesh Pujary",
year = "2013",
month = "7",
day = "1",
doi = "10.4103/0971-7749.117476",
language = "English",
volume = "19",
pages = "114--117",
journal = "Indian Journal of Otology",
issn = "0971-7749",
publisher = "Indian Journal of Otology",
number = "3",

}

TY - JOUR

T1 - Efficacy of mometasone nasal spray in the treatment of otitis media with effusion in the pediatric age group

T2 - A preliminary study

AU - Menon, Shalini

AU - Rahman, Abdul

AU - Balakrishnan, Ramaswamy

AU - Nayak, Dipak

AU - Pujary, Kailesh

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Aims: To study the efficacy of mometasone furoate monohydrate topical nasal spray in the treatment of otitis media with effusion (OME) in children aged between 4 and 15 years. Thus, by comparative analysis of results, at 0 and 6 weeks of using mometasone nasal spray, its efficacy in improving the clinical and audiological status of children with OME is assessed. Materials and Methods: A prospective, clinical study carried out on 22 children aged between 4 and 15 years who had attended our Department of Otolaryngology in a tertiary care hospital from January 2008 to May 2009. Results: The efficacy of mometasone furoate monohydrate topical nasal spray in the resolution of middle ear fluid in children aged between 4 and 15 years with OME in this study group was observed to be significant (52.7%). A significant improvement in the overall symptoms was seen in the treatment group. There was good improvement in the audiological status also. Conclusion: Topical steroids can be an alternative to surgery in controlling OME. However, these results are only short-term; a long-term follow-up is necessary. Topical intranasal mometasone furoate therapy can be considered a good therapeutic option to OME. Nasal administration of this steroid is safe, reproducible, easily performed, and well tolerated by pediatric patients.

AB - Aims: To study the efficacy of mometasone furoate monohydrate topical nasal spray in the treatment of otitis media with effusion (OME) in children aged between 4 and 15 years. Thus, by comparative analysis of results, at 0 and 6 weeks of using mometasone nasal spray, its efficacy in improving the clinical and audiological status of children with OME is assessed. Materials and Methods: A prospective, clinical study carried out on 22 children aged between 4 and 15 years who had attended our Department of Otolaryngology in a tertiary care hospital from January 2008 to May 2009. Results: The efficacy of mometasone furoate monohydrate topical nasal spray in the resolution of middle ear fluid in children aged between 4 and 15 years with OME in this study group was observed to be significant (52.7%). A significant improvement in the overall symptoms was seen in the treatment group. There was good improvement in the audiological status also. Conclusion: Topical steroids can be an alternative to surgery in controlling OME. However, these results are only short-term; a long-term follow-up is necessary. Topical intranasal mometasone furoate therapy can be considered a good therapeutic option to OME. Nasal administration of this steroid is safe, reproducible, easily performed, and well tolerated by pediatric patients.

UR - http://www.scopus.com/inward/record.url?scp=84884545405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884545405&partnerID=8YFLogxK

U2 - 10.4103/0971-7749.117476

DO - 10.4103/0971-7749.117476

M3 - Article

VL - 19

SP - 114

EP - 117

JO - Indian Journal of Otology

JF - Indian Journal of Otology

SN - 0971-7749

IS - 3

ER -